Retatrutide in New York (2026)
retatrutide · GLP-1 weight management · New York-specific guide
About Retatrutide
Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.
See the full Retatrutide review for dosing, efficacy data, side effects, and the full pharmacy + telehealth program comparison.
Insurance coverage for Retatrutide in New York
New York Medicaid covers Wegovy for BMI ≥35 with comorbidity after prior authorization. Step therapy through lifestyle program required.
Carrier-level coverage data for Retatrutide is not yet tracked in our database for $New York. Check your specific plan's formulary or our insurance hub.
Telehealth and prescribing in New York
New York permits interstate telehealth with state-licensed clinicians. Required to follow standard NY medical board rules.
Major platforms with active New York availability that may prescribe Retatrutide: Ro Body, Hims Weight Loss, Calibrate. Each platform varies in which drugs they prescribe, insurance handling, and clinical model. See our platform comparisons for details.
Compounded Retatrutide in New York
New York Board of Pharmacy has actively enforced FDA 2026 guidance; routine compounded semaglutide for weight loss is being shut down.
See our guide on the FDA compounding shutdown for the national context.
Retatrutide in New York — frequently asked
Is Retatrutide legal in New York?+
Yes. Retatrutide (retatrutide) is FDA-approved and legal in all 50 US states including New York. State-level differences appear in insurance coverage, telehealth prescribing rules, and (for GLP-1s) compounding pharmacy access — not in the underlying legality of the medication itself.
Can I get Retatrutide via telehealth in New York?+
New York permits interstate telehealth with state-licensed clinicians. Required to follow standard NY medical board rules. Major US telehealth platforms operating in New York that may prescribe Retatrutide include Ro Body, Hims Weight Loss, Calibrate. Each platform handles insurance and prescribing differently — see our platform comparisons for details.
Does New York Medicaid cover Retatrutide?+
New York Medicaid covers Wegovy for BMI ≥35 with comorbidity after prior authorization. Step therapy through lifestyle program required. For Retatrutide specifically: Medicaid coverage of GLP-1s for weight loss varies dramatically by state and indication. Diabetes indications are easier to get covered than weight-loss-only indications.
What's the cheapest way to get Retatrutide in New York?+
For Retatrutide in New York, the three main paths are: (1) insurance with prior authorization if your plan covers it (often $0-$25 copay), (2) manufacturer self-pay programs (NovoCare for Wegovy/Ozempic, LillyDirect for Zepbound/Mounjaro/Orforglipron), (3) telehealth bundles that include the medication. Direct-pay manufacturer programs typically beat retail pharmacy prices in 2026.
Is compounded Retatrutide still available in New York?+
New York Board of Pharmacy has actively enforced FDA 2026 guidance; routine compounded semaglutide for weight loss is being shut down. The FDA proposed permanently ending large-scale 503B compounding of semaglutide and tirzepatide on April 30, 2026. Individualized 503A compounding for documented clinical need may continue in New York, but routine 'cheaper alternative' compounding is being shut down.